Thank you very much, Mr. Chair.
Each one of you here today has used the words “awareness”, “best practices”, “data collection”, “science”, and “reasoning”. I will bring up a term that is widely used: “medical marijuana”. I don't believe there is any awareness of it. I don't believe there are any best practices for it. I don't believe there's been any data collection whatsoever. There's been very little science done on it. There's very little reasoning as to why we're doing it, especially when we have synthetic models of Marinol, nabiximol, and dronabinol, which provide opportunities for those who are affected by some significant diseases and can aid them.
Seeing that a doctor can prescribe medical marijuana without it going through a pharmacy, I'm curious to hear your perspective, given the addiction issues you've seen, on two things. One, do you believe that marijuana can be an addictive drug; and two, from the perspective of medical marijuana, what needs to be done to ensure that that it is safely prescribed to those who fall under the prescription of a medical doctor?
I'll start with whoever wants to start. You have about one minute each.
Dr. Buckley, you seem to be quite enthralled. Go ahead.